J&J Recalling OTC Domperidone After UK Concludes Drug Requires Prescription

Drug Industry Daily
Johnson & Johnson is pulling its OTC nausea and vomiting drug domperidone from the UK market following a decision by regulators that the medicine must require a prescription to obtain due to risks of serious cardiac effects.

To View This Article:


Subscribe To Drug Industry Daily